Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Inferiority Assessment of Valacyclovir Versus Valganciclovir as Prophylaxis Against CMV and EBV Viremia in Kidney Transplant Recipients: A Single-Center Prospective Randomized Pilot Study.

NCT07294547 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT07294547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07294547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Inferiority Assessment of Valacyclovir Versus Valganciclovir as Prophylaxis Against CMV and EBV Viremia in Kidney Transplant Recipients: A Single-Center Prospective Randomized Pilot Study.
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 27, 2025
Completion date
December 31, 2030
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiviral prophylaxis, ebv infection, kidney transplantation, cytomegalovirus infections